文献速递睡眠呼吸障碍

OSA治疗对货币化健康经济结局影响的系统综述

The Impact of Treatments for OSA on Monetized Health Economic Outcomes: A Systematic Review.
PubMed 文献 · Chest · 2019-01-18

该系统综述检索PubMed、Embase和Cochrane数据库,最终纳入17项研究,评估OSA治疗对货币化健康经济结局的影响。最常见的治疗为气道正压,最常见结局为医疗资源使用和QALYs,随访6周至5年。18项比较中15项显示治疗带来正向经济影响,治疗依从性和OSA严重程度与成本效果正相关。

要点

  • OSA治疗与有利经济结局相关,包括QALYs在可接受成本效果范围内、医疗资源使用减少和货币化成本降低。
  • 治疗依从性和OSA严重程度与成本效果正相关。
  • 研究方法差异大,但证据一致提示OSA治疗具有正向经济影响。

核心结论

  • 尽管研究方法差异广泛,证据一致表明OSA治疗与有利经济结局相关,包括QALYs在可接受成本效果范围内、医疗资源使用减少和货币化成本降低。

研究设计与样本

  • 系统综述,在PubMed、Embase和Cochrane Central Register of Controlled Trials数据库进行定制结构化检索,并分析合格研究的参考文献列表。
  • 检索识别2017条非冗余摘要,196篇全文文章被选进行综述,17项研究符合纳入标准进入最终综合。

主要发现

  • 气道正压是最常见治疗方式,但也包括口腔矫治器和手术方法。
  • 最常见健康经济结局为医疗资源使用和QALYs,随访范围从6周到5年。
  • 18项比较中15项发现OSA治疗带来正向经济影响。
  • 治疗依从性和OSA严重程度与成本效果正相关。

临床怎么用

  • 临床可参考本综述证据,OSA治疗在可接受成本效果范围内与QALYs改善、医疗资源使用减少和货币化成本降低相关。
  • 治疗依从性和OSA严重程度与成本效果正相关,临床应关注提高治疗依从性。

局限性

  • 研究 methodologies 差异广泛。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To review systematically the published literature regarding the impact of treatment for OSA on monetized health economic outcomes. METHODS: Customized structured searches were performed in PubMed, Embase (Embase.com), and the Cochrane Central Register of Controlled Trials (Wiley) databases. Reference lists of eligible studies were also analyzed. Titles and abstracts were examined, and articles were identified for full-text review. Studies that met inclusion criteria were evaluated in detail, and study characteristics were extracted using a standardized template. Quantitative characteristics of the studies were summarized, and a qualitative synthesis was performed. RESULTS: Literature searches identified 2,017 nonredundant abstracts, and 196 full-text articles were selected for review. Seventeen studies met inclusion criteria and were included in the final synthesis. Seven studies included formal cost-effectiveness or cost-utility analyses. Ten studies employed cohort designs, and four studies employed randomized controlled trial or quasi-experimental designs. Positive airway pressure was the most common treatment modality, but oral appliances and surgical approaches were also included. The most common health economic outcomes were health-care use (HCU) and quality-adjusted life years (QALYs). Follow-ups ranged from 6 weeks to 5 years. Overall, 15 of 18 comparisons found that treatment of OSA resulted in a positive economic impact. Treatment adherence and OSA severity were positively associated with cost-effectiveness. CONCLUSIONS: Although study methodologies varied widely, evidence consistently suggested that treatment of OSA was associated with favorable economic outcomes, including QALYs, within accepted ranges of cost-effectiveness, reduced HCU, and reduced monetized costs.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Wickwire EM, Albrecht JS, Towe MM, et al. The Impact of Treatments for OSA on Monetized Health Economic Outcomes: A Systematic Review. Chest. 2019. PMID: 30664857. doi:10.1016/j.chest.2019.01.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。